SE451069B - Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom - Google Patents

Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom

Info

Publication number
SE451069B
SE451069B SE8000245A SE8000245A SE451069B SE 451069 B SE451069 B SE 451069B SE 8000245 A SE8000245 A SE 8000245A SE 8000245 A SE8000245 A SE 8000245A SE 451069 B SE451069 B SE 451069B
Authority
SE
Sweden
Prior art keywords
hydroxy
propoxy
dihydrocarbostyril
carbon atoms
butylamino
Prior art date
Application number
SE8000245A
Other languages
English (en)
Swedish (sv)
Other versions
SE8000245L (sv
Inventor
N Tanaka
Y Nishinakamura
K Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26345304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE451069(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP54010108A external-priority patent/JPS5951927B2/ja
Priority claimed from JP54070361A external-priority patent/JPS5951928B2/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8000245L publication Critical patent/SE8000245L/xx
Publication of SE451069B publication Critical patent/SE451069B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8000245A 1979-01-30 1980-01-11 Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom SE451069B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP54010108A JPS5951927B2 (ja) 1979-01-30 1979-01-30 緑内障治療剤
JP54070361A JPS5951928B2 (ja) 1979-06-04 1979-06-04 緑内障治療剤

Publications (2)

Publication Number Publication Date
SE8000245L SE8000245L (sv) 1980-07-31
SE451069B true SE451069B (sv) 1987-08-31

Family

ID=26345304

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8000245A SE451069B (sv) 1979-01-30 1980-01-11 Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom

Country Status (15)

Country Link
US (1) US4309432A (fr)
AT (1) AT371340B (fr)
AU (1) AU518814B2 (fr)
CA (1) CA1139669A (fr)
CH (1) CH646057A5 (fr)
DE (1) DE3001011C2 (fr)
DK (1) DK11580A (fr)
ES (1) ES8100268A1 (fr)
FI (1) FI800089A (fr)
FR (1) FR2447721A1 (fr)
GB (1) GB2042338B (fr)
IT (1) IT1141662B (fr)
NL (1) NL191575C (fr)
NO (1) NO800059L (fr)
SE (1) SE451069B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056420A1 (fr) * 1981-01-15 1982-07-28 Schering Corporation Gel ophtalmique
FR2539413A1 (fr) * 1983-01-17 1984-07-20 Pos Lab Carbostyriloximinopropanolamines utiles comme medicaments et procede pour leur preparation
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
US4921862A (en) * 1986-05-29 1990-05-01 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors
US5198448A (en) * 1988-08-10 1993-03-30 Otsuka Pharmaceutical Company, Limited Cardiotonics
EP0355583B1 (fr) * 1988-08-10 1995-01-25 Otsuka Pharmaceutical Co., Ltd. Agents cardiotoniques
DE69019774T2 (de) * 1989-03-28 1995-11-09 Nisshin Flour Milling Co Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
FR2676740B1 (fr) * 1991-05-23 1993-11-05 Roussel Uclaf Nouveaux derives sterouides du pregna-4,9(11),17(20)-trie-3-one, leur preparation, leur application a la preparation de composes sterouides de type pregna-4,9(11),16-triene-3,20-dione et nouveaux intermediaires.
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
MY116782A (en) 1997-12-22 2004-03-31 Otsuka Pharma Co Ltd Water-soluble eye drop
BRPI0719396A2 (pt) * 2006-12-06 2014-02-18 United States Borax Inc Composição de ração animal, uso de boro suplementar e vitamina c suplementar e método não terapêutico para aumentar a eficiência de absorção de fósforo em um animal, diminuir a quantidade de fósforo excretada por um animal, ou reduzir a poluição de fósforo ambiental em uma fazenda de criação

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS517672B2 (fr) * 1972-04-13 1976-03-10
US3910924A (en) * 1972-04-13 1975-10-07 Otsuka Pharma Co Ltd 3,4-Dihydrocarbostyril derivatives and a process for preparing the same
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5239035B2 (fr) * 1972-12-14 1977-10-03
US3975391A (en) * 1973-12-26 1976-08-17 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US3953546A (en) * 1973-07-31 1976-04-27 Sumitomo Chemical Company, Limited Thio(dithio)phosphorates
JPS5082218A (fr) * 1973-11-10 1975-07-03
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH619453A5 (fr) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
GB1574665A (en) * 1976-05-08 1980-09-10 Otsuka Pharma Co Ltd 3,4-dihydrocarbostyril derivatives and process for preparing the same
JPS552631A (en) * 1978-06-19 1980-01-10 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril derivative
JPS5513241A (en) * 1978-07-14 1980-01-30 Otsuka Pharmaceut Co Ltd Remedy for glaucoma

Also Published As

Publication number Publication date
NO800059L (no) 1980-07-31
FR2447721A1 (fr) 1980-08-29
DE3001011A1 (de) 1980-08-28
CA1139669A (fr) 1983-01-18
GB2042338B (en) 1983-11-30
DK11580A (da) 1980-07-31
IT8005106A0 (it) 1980-01-09
FI800089A (fi) 1980-07-31
NL8000211A (nl) 1980-08-01
NL191575C (nl) 1995-10-03
AU518814B2 (en) 1981-10-22
ES487642A0 (es) 1980-11-01
ES8100268A1 (es) 1980-11-01
NL191575B (nl) 1995-06-01
DE3001011C2 (de) 1986-02-06
ATA14480A (de) 1982-11-15
SE8000245L (sv) 1980-07-31
IT1141662B (it) 1986-10-08
GB2042338A (en) 1980-09-24
AT371340B (de) 1983-06-27
FR2447721B1 (fr) 1983-03-11
CH646057A5 (de) 1984-11-15
AU5426579A (en) 1980-08-07
US4309432A (en) 1982-01-05

Similar Documents

Publication Publication Date Title
US5061714A (en) Isoquinoline composition for the treatment of glaucoma or ocular hypertension
US4910225A (en) Locally administrable therapeutic composition for inflammatory disease
EP0235544B1 (fr) Composition oculaire antihypertensive pour l'utilisation topique
CA2029657C (fr) Compositions pharmaceutiques permettant de reduire la tension intra-oculaire et mode d'utilisation
SE451069B (sv) Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom
EP2114398B1 (fr) Dérivés de mononitrate d'isosorbide pour le traitement de l'hypertension oculaire
US4861783A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
EP0633025A1 (fr) Composition pharmaceutique contenant du 3-méthyl-1-phényl-2-pyrazolin-5-one pour le traitement des maladies ophthalmiques
RU2027435C1 (ru) Вещество, снижающее внутриглазное давление
KR980008226A (ko) 시각기능장애의 예방 및 치료제
EP0140789B1 (fr) Utilisation d'antagonistes de dopamine périphérique sélectifs pour la fabrication d'un médicament pour le traitement topique de l'hypertension oculaire
JP3066561B2 (ja) 近視予防・治療剤
US4322425A (en) Compositions for treating glaucoma
SE451070B (sv) Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom
EP0728480A1 (fr) Utilisation d'ifenprodil pour le traitement de la pression intraoculaire élevée
EP0277814B1 (fr) Utilisation de trifluorométhanesulfonamide contre le glaucome
CA2644810A1 (fr) Agent prophylactique ou therapeutique pour la maladie ophthalmique allergique ou la maladie nasale allergique comprenant un derive tricycliqued e triazolobenzoazepine
US5252583A (en) Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
US5428030A (en) Method of reducing elevated intraocular pressure
JPS6232171B2 (fr)
US4826812A (en) Antiglaucoma agent
JPH04134029A (ja) 緑内障治療剤
JPS5951928B2 (ja) 緑内障治療剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8000245-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8000245-4

Format of ref document f/p: F